Top compounds associated with response to SLC26A5


Feature Type Standardized
Nominal ANOVA
mRNA neopeltolide CTRPv2 pan-cancer AAC -0.17 0.01
mRNA Doxorubicin gCSI pan-cancer AAC -0.16 0.001
mRNA Docetaxel gCSI pan-cancer AAC -0.16 0.003
mRNA paclitaxel gCSI pan-cancer AAC -0.14 0.006
mRNA Gemcitabine gCSI pan-cancer AAC -0.13 0.02
mRNA pluripotin CTRPv2 pan-cancer AAC -0.11 0.002
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.11 0.0007
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.11 0.003
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA MG-132 GDSC1000 pan-cancer AAC -0.1 0.04
Download CSV